Milton C. Ault III - 22 Dec 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
22 Dec 2023
Net transactions value
+$635
Form type
4
Filing time
27 Dec 2023, 16:30:16 UTC
Previous filing
11 Mar 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $185 +200 +0.12% $0.9242 166,866 22 Dec 2023 Direct
transaction ALZN Common Stock Purchase $450 +500 +2% $0.9000 26,032 26 Dec 2023 By Ault Alpha LP F1
holding ALZN Common Stock 737,333 22 Dec 2023 By Ault Lending, LLC F2
holding ALZN Common Stock 996,198 22 Dec 2023 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 666,666 22 Dec 2023 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.